Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Scandinavian Life Science Två AB
AB
Active
Org 5590153531
Stockholm
Rental and operating of own or leased real estate
· NACE 6820
Est. 2015
0 employees
Watchlist
Share
Sweden
/
Companies
/
Rental and operating of own or leased real estate
/
Scandinavian Life Science Två AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
37M
74M
111M
148M
40M
2020
101M
2021
109M
2022
122M
2023
129M
2024
EBITDA
SEK millions
0M
25M
50M
75M
100M
27M
2020
87M
2021
86M
2022
-53M
2023
-50M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
40 078
101 388
108 509
122 154
128 597
Staff expenses
—
—
—
—
—
EBITDA
26 571
86 647
86 352
−53 338
−50 395
Depreciation & amort.
−0
−0
—
—
—
EBIT
26 571
86 647
86 352
−53 338
−50 395
Net financials
−16 239
−32 500
−32 584
−33 982
−18 496
Profit before tax
10 332
2 810
−33 075
27 381
22 960
Tax
−16 236
−4 353
106
−819
−4 724
Net profit
−5 904
−1 543
−32 969
26 562
18 236
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
2 195 607
2 388 190
2 370 052
2 590 961
2 058 552
Equity
6 371
4 828
11 859
338 421
356 657
Long-term debt
2 140 000
2 140 000
2 140 000
2 140 000
0
Short-term debt
37 888
232 039
206 976
96 644
1 681 276
Total debt
2 177 888
2 372 039
2 346 976
2 236 644
1 681 276
Financial ratios
5-year trend
EBITDA margin
-39.2%
This company
15.8%
Market median
-348% vs market
2020
2024
Equity ratio
17.3%
This company
38.2%
Market median
-55% vs market
2020
2024
Return on equity
5.1%
This company
18.4%
Market median
-72% vs market
2020
2024
Net profit margin
14.2%
This company
8.1%
Market median
+75% vs market
2020
2024
Asset turnover
0.06×
This company
1.12×
Market median
-95% vs market
2020
2024
Debt / equity
4.77×
This company
0.62×
Market median
-669% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Scandinavian Life Science Två AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
